MVC advert_160x160
News
Incyte and Genesis Therapeutics enter strategic collaboration focused on novel small molecule medicines
Incyte and Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines, with an initial...
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
The Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment...
Infex signs exclusive license agreement with Venus Remedies to advance MET-X through clinical development...
Infex Therapeutics, an anti-infectives specialist, has signed an exclusive license agreement for the Indian market with Venus Remedies, an Indian pharmaceutical company, for the...
